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Abstract
Background: Tight-junction (TJ) protein degradation is a decisive step in hypoxic blood-brain barrier (BBB) breakdown in
stroke. In this study we elucidated the impact of acute cerebral ischemia on TJ protein arrangement and the role of the
apoptotic effector protease caspase-3 in this context.
Methodology/Principal Findings: We used an in vitro model of the neurovascular unit and the guinea pig whole brain
preparation to analyze with immunohistochemical methods the BBB properties and neurovascular integrity. In both
methodological approaches we observed rapid TJ protein disruptions after 30 min of oxygen and glucose deprivation or
middle cerebral artery occlusion, which were accompanied by strong caspase-3 activation in brain endothelial cells (BEC).
Surprisingly only few DNA-fragmentations were detected with TUNEL stainings in BEC. Z-DEVD-fmk, an irreversible caspase-
3 inhibitor, partly blocked TJ disruptions and was protective on trans-endothelial electrical resistance.
Conclusions/Significance: Our data provide evidence that caspase-3 is rapidly activated during acute cerebral ischemia
predominantly without triggering DNA-fragmentation in BEC. Further we detected fast TJ protein disruptions which could
be partly blocked by caspase-3 inhibition with Z-DEVD-fmk. We suggest that the basis for clinically relevant BBB breakdown
in form of TJ disruptions is initiated within minutes during ischemia and that caspase-3 contributes to this process.
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Introduction
In vivo the blood-brain barrier (BBB) together with its neuronal
and non-neuronal surrounding represents the neurovascular unit
(NVU)[1], which ischaracterized by a functionalinteraction between
brain endothelial cells (BEC), astrocytes, pericytes, microglia and
neurons. BEC effectively separate the brain from cerebral blood flow
through a complex and precisely regulated system of tight-junction
(TJ) proteins [2]. Ischemic conditions induce a breakdown of the BBB
which leads to numerous severe clinical complications like brain
edema formationandneuroinflammation [3,4]. Itiswelldocumented
that TJ proteins play a pivotal role in hypoxic BBB injury [5,6].
Therefore a better understanding of TJ pathophysiology in acute
cerebral ischemia may improve treatment strategies in stroke.
Numerous studies have demonstrated a neuroprotective effect of
the irreversible caspase-3 inhibitor Z-DEVD-fmk under ischemic
conditions [7–10]. It is further known that proteases (e. g. caspase-
3, matrix metallo proteases) are involved in ischemic BEC damage
[11]. Clinical datasets showed that elevated serum levels of
caspase-3 are an indicator for infarct growth and poor outcome
after stroke [12]. A recent clinical trial reports that post-stroke
treatment with minocycline, a drug with multiple anti-apoptotic
effects, improves patient outcome [13]. It is well documented that
minocycline inhibits caspase-1 and caspase-3 expression in vivo
[14]. These investigations point to a significant involvement of
caspases in hypoxic cell damage in the brain.
We used a recently described model of the NVU [15] to analyze
(i) acute ischemic alterations of the NVU by immunohistochem-
istry of the TJ proteins Zonula occludens-1 (ZO-1) and Claudin-5
(Cl-5), which have a key role in the pathogenesis of ischemic
blood-brain barrier breakdown [6,15–17], and (ii) whether
caspase-3 is involved in altering TJ protein arrangement. To
strengthen the significance of our investigation we also performed
immunohistochemical analyzes of ZO-1 after middle cerebral
artery occlusion (MCAO) in the guinea pig isolated whole brain, in
which the BBB as NVU is completely preserved [18].
We observed a Rapid Anoxic Neurovascular Unit Damage
(RANUD) which was partly caused by caspase-3 mediated
degradation of the TJ proteins ZO-1 and Cl-5.
In contrast to previous findings [19,20] the results in our present
report indicate that the BBB in our models of the NVU is already
impaired after short periods of chemical oxygen and glucose
deprivation (OGD)/MCAO at the level of the TJs. Furthermore,
we identified caspase-3 to be significantly involved in ZO-1 and
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Based on our data we propose (i) that ischemic alterations of TJs in
the NVU differ significantly from the currently discussed concept
and (ii) that caspase-3 may be a target for therapeutic intervention
in acute cerebral ischemia to stabilize NVU integrity.
Materials and Methods
Cell culture
We used a murine brain endothelial cell line bEnd.3 (bEnd.3,
American Type Culture Collection, Manassas, Virginia, USA) for
coculture experiments as described previously [15]. bEnd.3 were
cultured as recommended by the manufacturer and maintained at
37uC and 5% CO2. Media consisted of DMEM Glutamax
supplemented with 2% Penicillin/Streptomycin (all from Invitro-
gen GmbH, Karlsruhe, Germany) and 15% fetal calf serum
(Biochrom AG, Berlin, Germany). For coculture procedures BEC
were grown until confluence was reached on glass coverslips.
Neurovascular unit model
We used a recently described murine coculture model consistent
of cortical organotypic slice cultures (COSC) and the murine brain
endothelial cell line bEnd.3 as documented in detail before [15].
All experiments were conducted in accordance with the national
and European (86/609/EEC) laws for the use of animals in
research and were approved by the local institutional animal care
committee. All efforts were made to minimize the number of
animals used and their suffering. A detailed description of the
coculture was documented previously [15].
A careful examination of the coculture with light microscopy for
intact cell morphology before starting experimental manipulations
was obligatory since dislocations of the COSC from bEnd.3 before
experimental manipulations occasionally occurred. Only cocul-
tures with firm adhesion of COSC on bEnd.3 coverslips and intact
cell shapes were used for experiments.
Guinea pig whole brain preparation
Experiments were performed on brains of young adult Hartley
guinea pigs (150–200 g; Charles River, Italy) isolated following the
standard technique described elsewhere [18,21,22]. Briefly, after
anaesthesia, the brain was carefully isolated and transferred to the
incubation chamber. A polyethylene cannula was inserted into the
basilar artery to ensure arterial perfusion with a complex saline
solution (composition in mmol/L: 126 NaCl, 3 KCl, 1.2 KH2PO4,
1.3 MgSO4, 2.4 CaCl2, 26 NaHCO3, 15 glucose and 3% dextran
MW 70.000) oxygenated with a 95% O2 -5 %C O 2 gas mixture
(pH 7.3). The rate of arterial perfusion was 7 ml/min. Experi-
ments were carried out at 32 uC. The experimental protocol was
approved by the Ethics Committee of the Fondazione Istituto
Neurologico ‘‘C.Besta’’, in accordance with National and
International guidelines on care and use of laboratory animals
(protocol number 45–46; 07/11/2003).
Dyes, chemicals and antibodies
2-deoxy-D-glucose, NaCN, propidium iodide (10 mg/l) and triton
X-100 were from Sigma-Aldrich (Steinheim, Germany); antibody
directed against the cleaved, active form of caspase-3 was from
Signaling Technology (Asp175, Cell Signaling Technology Inc.) [23];
polyclonal anti-ZO-1 (61–7300) and anti-claudin-5 (35–2500) were
from Zymed ordered via Invitrogen; polyclonal rabbit anti-gial
fibrillary acidic protein (GFAP) Z0334 was from DakoCytomation
(Glostrup Denmark); biotinylated goat anti-rabbit antibody was from
Vector Laboratories (Burlingame, CA, USA); Cy
TM3-conjugated
AffiniPure goat anti-rat IgG and Cy
TM2-conjugated AffiniPure goat
anti-rabbit IgG were from Dianova (Hamburg, Germany); Strepta-
vidin Alexa 488 and Alexa Fluor 568 goat anti-mouse were from
Molecular Probes; Streptavidin Cy3 was from Sigma (S6402,
Deisenhofen, Germany); Dylight
TM594-conjugated goat anti-rabbit
igG (from Jackson ImmunoResearch, West Grove, PA, USA); anti-
MAP-2 primary antibody (MAP-2 clone AP 20, Bio-Optica,
Fremont, CA, USA); monoclonal biotinylated horse anti-mouse
IgG (Vector Laboratories Inc., Burlingame, CA, USA); avidin-biotin
peroxidase protocol (ABC kit, Vector Laboratories Inc.); 3,39-
diamino-benzidine tetrhaydrochloride (DAB; Sigma, St Louise,
MO, USA); normal goat serum (from Jackson ImmunoResearch,
ordered via Dianova); Fluoromount was from Southern Biotech
(Birmingham, AL, USA); Fluorsave was from Calbiochem (San
Diego, CA, USA); TUNEL label mix and TUNEL enzyme were
both from Roche (Mannheim, Germany);bovine serum albuminwas
from Dianova; Z-DEVD-fmk was from Calbiochem.
Oxygen and glucose deprivation
OGD was induced by replacing culture media of the coculture
with HBSS supplemented with 2 mmol/l CaCl2, 1 mmol/l
MgCl2, 10 mmol/l 2-deoxy-D-glucose and 5 mmol/l sodium
cyanide. Exposure time was 30 min. For immunohistochemistry
cocultures undergoing OGD were gently washed in HBSS (37uC)
before fixation. The caspase-3 inhibitor Z-DEVD-fmk was
incubated for 2 hours at a concentration of 50 mmol/l before
OGD. A protective and non-toxic effect of Z-DEVD-fmk at this
concentration has been demonstrated previously [24].
Middle cerebral artery occlusion
The proximal portion of one of the middle cerebral artery
(MCA) was carefully isolated from the surrounding dura. A silk
thread was slid under the MCA and a loose node was prepared
around the vessel. To induce transient ischemia, the ends of the
loose silk thread positioned around the MCA were pulled by
tweezers and the MCA was occluded. MCAO of 30 min duration
was induced 90 min after in vitro placement.
Immunohistochemistry (IHC)
Coculture of the NVU. IHC stainings for ZO-1, Cl-5,
Caspase-3, GFAP and CD31 in the coculture model of the NVU
were performed as described previously [15]. In case COSC
dislocated from coverslips during washing procedures for IHC,
COSC were analyzed separately from bend3 monolayers on
coverslips for tight-junction integrity in cerebral microvessels.
Co-stainings of activated caspase-3 and Terminal deoxynucleo-
tidyl Transferase Biotin-dUTP Nick End Labeling (TUNEL) were
performed as follows: After experimental manipulation probes
were fixed in paraformaldehyde (4%) for 30 min at room
temperature (RT). Thereafter samples were permeabilzed in
0.1 mol/l tri-natrium citrate (freshly prepared) and 0.1% triton
X-100 for 2 min on ice in a multiwell plate. Then probes were
washed with phosphate buffer saline (PBS) 0.01 mol/l and
TUNEL-reaction mixture (50 ml/coculture) was added. Cocul-
tures were covered with parafilm and placed in a humidified
chamber (1 h, 37 uC). This was followed by blocking and
permeabilisation with 7% normal goat serum and 0.3% triton
X-100 in PBS 0.01 mol/l (2 h, RT). The primary antibody against
cleaved caspase-3 (dilution: 1:200 in 2% bovine serum albumin
with 0.05% acid and 0.1% triton X-100 in PBS 0.01 mol/l) was
incubated over night at RT. Samples were washed with PBS
0.01 mol/l, then secondary antibodies were incubated for 2 h at
RT: biotinylated goat anti-rabbit IgG (H+L) 1:200 and to enhance
TUNEL-signal Cy2-anti-FITC 1:400 diluted with 2% bovine
serum albumin with 0.05% acid was applied. Cells were washed
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PBS 0.01 mol/l (1:400, 1 h, RT), washed once again and finally
embedded in Fluoromount or Fluorsave. Activated caspase-3 and
propidium iodide (PI) were co-stained after fixation of the COSC
for 30 min in 4% paraformaldehyde followed by a careful wash in
0.01 mol/l PBS. Probes were blocked and permeabilized with 7%
normal goat serum and 0.3% triton-X100 in 0.01 mol/l PBS for
2 h at RT. Subsequently primary antibodies (dilution: 1:200 in 2%
bovine serum albumin with 0.05% acid and 0.1% triton X-100 in
0.01 mol/l PBS) against cleaved caspase-3 were incubated
overnight at RT. After washing with 0.01 mol/l PBS secondary
antibodies (biotinylated goat anti-rabbit IgG (H+L) 1:100 diluted
with 2% bovine serum albumin with 0.05% azide) were incubated
for 2 h at RT. Afterwards COSC were washed in 0.01 mol/l PBS
and were then incubated with Streptavidin Alexa 488 (in
0.01 mol/l PBS diluted at 1:400 for 1 h at RT). Samples were
washed again with 0.01 mol/l PBS, incubated with PI (1:400 for
10 min at RT) and embedded in Fluorsave.
Guinea pig isolated whole brain. For morphological
studies, the brains were perfused at the end of the experiment
via the basilary artery with a solution of paraformaldehyde-lysine-
periodate (PLP) in 0.1 mol/l phosphate buffer (PB), ph 7.4 for
10 min. Post-fixation was carried out in PLP for 2 h at RT. After
fixation, serial coronal sections (50 mm) were cut with a vibratome
(VT 1000S Leica Heidelberg, Germany).
Selected free-floating vibratome sections were incubated in
0.01 mol/l PBS containing 1% bovine serum albumin and 0.2%
triton X-100. Sections were then incubated overnight at 4 uC with
anti-ZO-1 primary antibody (1:400). Then the slices were rinsed in
PBS and were incubated for 2 h at RT in a Dylight
TM594-
conjugated goat anti-rabbit igG (1:600) and, after repeated rinsing,
were mounted in Fluorosave and were examined under a confocal
laser scanning microscope.
For microtubule-associated protein (MAP-2) staining, the
brains were fixed by immersion in a cold 4% paraformaldehyde
solution in 0.1 M PB, pH 7.4. On the next day, the brains were
cut in serial coronal sections as described before. Selected free-
floating slices were incubated in 0.01 M phosphate buffered
saline (PBS) containing 10% normal horse serum (NHS) and
0.2% triton X-100. Sections were then incubated overnight at 4
uC with anti-MAP-2 primary antibody (1:1000), diluted in 1%
NHS in PBS. Then the slices were rinsed in PBS and were
incubated for 75 min in monoclonal biotinylated horse anti-
mouse IgG (1:200; Vector Laboratories Inc., Burlingame, CA,
USA). The avidin-biotin peroxidase protocol (ABC jı `kit, Vector
Labs) was applied, using 3.39-diamino-benzidine tetrhaydrochlor-
ide (DAB; Sigma, St Louise, MO, USA) as chromogen. After
staining, sections were dehydrated, cleared with xilene and
coverslipped with DPX.
Immunofluorescence confocal microscopy (ICM)
For ICM we used an upright microscope (BX51WI, Olympus;
Hamburg, Germany), equipped with a Nipkow spinning disk
confocal system (QLC10 Visitech, Sunderland, United Kingdom)
and a Krypton/Argon laser (Laser Physics, Cheshire, UK) and a
confocal laser scanning microscope (Nikon D-ECLIPSE C1).
Fluorescent probes were excited at 488 nm and 568 nm. Images
were analysed using Metamorph imaging software (Molecular
Devices Corp., Downington, CA, USA).
Measurements of trans-endothelial electrical resistance
(TEER)
TEER was analyzed with electrical cell impedance sensing
(ECIS) as described in detail before [15]. bEnd.3 were seeded at a
density of approximately 50,000 cells per well in an 8 well gold
electrode ECIS assay (0.8 cm
2 growth area, ibidi in cooperation
with Applied BioPhysics, Martinsried, Germany). bEnd.3 media
were refreshed after 1 day and COSC were gently transferred into
the wells. When impedance measurements reached maximal
values (cocultures reached TEER values of 890.9617.9
OHM6cm
2), OGD was induced to monitor in vitro ischemia-
induced BBB breakdown.
Quantification of Caspase-3 immunoreactivity
To quantify caspase-3 immunoreactivity we combined PI
stainings of brain endothelial cell nuclei with cleaved caspase-3
antibody staining. Three randomly chosen fields of view (RFV,
magnification 606) per probe (n=3 coculture preparations -.9
RFV per probe) in the bEnd.3 monolayer area were acquired
under normoxic and OGD conditions. The cell number of each
field was determined by counting PI positive cell nuclei. The RFV
were divided into 25 fields and caspase-3 positive fields were
subsequently counted. The number of immunoreactive caspase-3
quadrants in the RFV was divided through the cell number of
each RFV. As a result the amount of active caspase-3 fields per cell
in% was obtained.
Quantification of tight-junction impairment
Length of TJ disruption was measured (in pixels) and related to
the whole length of ZO-1 and Cl-5 staining in corresponding
microvessels (modified according to [25]). TJ disruptions in
percentage (%) are presented. Only vessels that were immunore-
active for both ZO-1 and Cl-5 were used for quantification. For
each condition at least 26 microvessels from 6-7 coculture
preparations were analyzed. For quantification of TJ impairment
in the brain endothelial monolayer area of the NVU in vitro
model, we used Metamorph imaging software similar as
documented before [26]. Cells were analyzed with linescan
measurements and intensity histograms. Intensity values at the
cell membranes (represented by Value 1: V1 and Value 3: V3)
were measured and set in relation to the average intensity of the
cytoplasm (average value of the distance between V1 and V3 -.
Value 2: V2) of the corresponding cell. The following formula was
used for calculation of the relative intensity values of ZO-1 and Cl-
5: [(V1+V3)/2] /V2.
For each condition 12 arbitrarily chosen cells from 3 coculture
preparations were analyzed.
Statistics
Results are expressed as mean values 6 s.e.m. A value of
P,0.05 was considered as significant. Statistically significant
effects of OGD on differences in TEER values, TJ damage and
cleaved caspase-3 levels were assessed by t-test analyses.
Results
Expression of ZO-1 and Cl-5 in cortical microvessels of
the in vitro neurovascular unit model
Survival of microvessels in cortical organotypic slice cultures is
critical [27]. We found cortical microvessels with an intact
morphology in the cortical area of our in vitro NVU model
[15]. Immunofluorescence images of CD31 (Fig. 1A, B) show an
intact microvascular morphology. We found endfeet of astrocytes
in contact with CD31 positive microvessels (Fig. 1C). Antibody
staining against the TJ proteins ZO-1 and Cl-5 revealed a
prominent expression of these proteins within the cortical
microvessels (Fig. 1D–F).
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oxygen and glucose deprivation and effects of Z-DEVD-
fmk on tight-junction integrity and TEER
Under normoxic conditions a continuous alignment of Cl-5 and
ZO-1 could be observed (Fig. 2A, D). OGD for 30 minutes
induced a disruption of Cl-5 and ZO-1 in the monolayer area of
the NVU model (arrowheads and insets in Fig. 2B, E). In order to
address the question whether the activation of caspase-3
contributes to the detected rapid TJ impairment, we applied the
caspase-3 inhibitor Z-DEVD-fmk [28]. Z-DEVD-fmk had a
protective effect on TJ integrity. Only a few disruptions were
visible in probes pre-treated with Z-DEVD-fmk (arrowheads in
Fig. 2C, F) after OGD. However, the disruption of ZO-1 and Cl-5
was not completely abolished. Furthermore, Z-DEVD-fmk partly
reduced caspase-3 activation (Fig. 2G, H). Because trans-
endothelial electrical resistance (TEER) correlates with blood-
brain barrier integrity [19] we also performed TEER measure-
ments and observed that pre-treatment with Z-DEVD-fmk
preserved NVU integrity. TEER values of probes treated with
Z-DEVD-fmk had significantly higher TEER values after OGD
compared with probes that were not treated with the inhibitor
(Fig. 2I, Z-DEVD-fmk: 317.3615.5 OHM6cm
2 vs. no inhibitor
266.167.7 OHM6cm
2,P ,0.05, n=6 coculture preparations),
which correlates well with our immunohistological findings
(Fig. 2B, C, E and F). To quantify the observed TJ damage in
the monolayer area of our NVU in vitro model we analyzed the
localization of ZO-1 and Cl-5 in BEC with linescan measurements
similar as described previously by Brown and colleagues [26]. It is
known that BBB breakdown correlates with a redistribution of TJ
from the plasma membrane to the cytoplasm which goes along
with TJ disruptions [29]. To quantify subcellular TJ redistributions
the intensity of ZO-1 and Cl-5 in BEC was measured with
linescans. Intensity values at cell borders were set in relation to the
average intensity of the cytoplasm.
Cells that were not pre-treated with Z-DEVD-fmk (Fig. 3A, B)
had reduced intensity values of relative ZO-1 staining at cell
membranes. In contrast, pre-treatment with Z-DEVD-fmk
preserved intact ZO-1 localization (Fig. 3C, D) as demonstrated
by clear peak values of ZO-1 at cell borders in linescan histograms.
Localization of ZO-1 in cell membranes was significantly higher if
cells were pre-treated with Z-DEVD-fmk (Fig. 3E, no inhibitor:
1.2460.1 vs. Z-DEVD-fmk: 1.8460.1, n=12 cells from 3
coculture preparations, P,0.001). Similar results were obtained
for Cl-5. Z-DEVD-fmk also had a protective effect on Cl-5 under
OGD. OGD caused a loss of peak values in BEC cell membranes
(Fig. 3F and G). Z-DEVD-fmk sustained clear peak values of Cl-5
staining at the cell membrane (Fi. 3 H, I and J: no inhibitor:
1.960.21 vs. Z-DEVD-fmk: 3.1960.41, n=12 cells from 3
coculture preparations, P,0.05).
Analogous to the TJ damage in the BEC monolayer area of the
NVU model, OGD resulted in prominent disruptions of ZO-1 and
Cl-5 in cortical microvessels (arrowheads Fig. 4A–D; G–I).
Quantification of TJ disruptions in cortical microvessels revealed
that Z-DEVD-fmk significantly reduced the amount of gap
formations (Fig. 4J–O) in both junctional proteins Cl-5 (Fig. 4E,
15.3361.32% no inhibitor vs. 4.6960.84% +Z-DEVD-fmk,
P,0.001, n=28-46 microvessels, 6–7 coculture preparations)
and ZO-1 (Fig. 4F, 23.8762.15% no inhibitor vs. 12.5962.15%
+Z-DEVD-fmk, P,0.001, n=26-42 microvessels, 6–7 coculture
preparations).
Evaluation of ZO-1 and MAP-2 immunohistochemistry in
the guinea pig isolated whole brain after MCAO
Morphological brain tissue evaluation performed at the end of
30 min of MCAO confirmed the presence of post-ischemic
changes in brains either in ZO-1 and MAP-2 staining. ZO-1
staining showed a preservation of the endothelial junctional
molecule ZO-1 in the control hemisphere (Fig. 5A–C). MAP-2 is a
sensitive marker for early hypoxic brain tissue damage [30,31].
Figure 1. Expression of ZO-1 and Cl-5 in cortical microvessels of
the neurovascular unit in vitro model. (A, B) CD31 stainings
demonstrating preservation of microvascular morphology in the COSC of
the coculture. (C), Endfeet of Astrocytes (arrowheads in C) contacting
CD31 positive microvessels. D-F, Microvessels express the tight-junction
proteins ZO-1 (panel D) and Claudin-5 (panel E), which show a co-
localization(panelF).Scalebars inCandF:20 mm;inA,BandD,E:20 mm.
doi:10.1371/journal.pone.0016760.g001
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hemisphere (Fig. 5D), as shown by the homogeneous staining
across cortical regions whereas the MAP-2 signal was markedly
reduced in brain areas supplied by the occluded MCA (Fig. 5D).
Here, a strong impairment of ZO-1 alignment is present in the
ischemic hemisphere, as demonstrated by the numerous discon-
tinuities in cortical vessels (Fig. 5E–H).
Caspase-3 activation and TUNEL staining after 30 min of
oxygen and glucose deprivation
Caspase-3 is mainly regarded as a major apoptosis effector
protease and was found to be involved in brain endothelial
cytotoxicity in hypoxia followed by reoxygenation [11]. Data from
patients with high serum levels of caspase-3 point to a poor
outcome after stroke compared to patients with low serum levels of
caspase-3 [12]. Therefore we were interested in the question
whether caspase-3 also has a significant role in fast responses of the
NVU in acute cerebral ischemia. We performed double stainings
of caspase-3 and TUNEL to analyze whether the activation of
caspase-3 is related with DNA-fragmentation, a hallmark for
apoptosis [32]. Surprisingly we observed that only a few cells with
activated caspase-3 were localized in TUNEL-positive cells
(Fig. 6A–F). Levels of activated caspase-3 were higher after
30 min of OGD compared with normoxic conditions (Fig. 6G-I).
Values were 16.8562.78% caspase-3 positive fields per cell
(normoxia) vs. 31.3165.71% caspase-3 positive fields per cell
(hypoxia, n=3 coculture preparations, P,0.05; Fig. 6G).
Discussion
The main findings of our investigation are: i) The impairment of
the TJ proteins already occurs after 30 min OGD (ZO-1 and Cl-5)
and MCAO (ZO-1), we refer to this observation as Rapid Anoxic
Neurovascular Unit Damage (RANUD); ii) caspase-3 is strongly
activated during 30 min of OGD, contributes to TJ disorganisa-
tion and is only partly associated with DNA-fragmentation; iii) Z-
DEVD-fmk has a protective effect on TJ protein arrangement and
TEER in OGD.
Previous investigations have documented that disorganisation of
TJ proteins are likely to occur within hours to days after ischemia,
especially in models of ischemia followed by reperfusion
[3,6,16,20,33,34]. Studies that were performed in vitro have
mostly used models that lack a preserved neuronal compartment
Figure 2. Application of Z-DEVD-fmk preserves TEER and TJ monolayer integrity under OGD. (A-F) Continuous expression of Cl-5 (panel
A) and ZO-1 (panel D) under normoxic conditions. After 30 min of OGD Cl-5 and ZO-1 are prominently disrupted (arrowheads and insets in B and E)
and display a ragged shape. Analogous to the protective effect of Z-DEVD-fmk on TEER (panel I), Z-DEVD-fmk also has a protective effect on ZO-1 and
Cl-5 expression, but does not completely prevent TJ disruption (arrowheads in C and F). (G) Immunohistochemical co-staining with propidium iodide
(red) and caspase-3 (green) shows high amounts of cleaved caspase-3 after OGD which are lowered by pre-treatment with Z-DEVD-fmk (H). I, Pre-
treatment with 50 mmol/l Z-DEVD-fmk for 2 hours preserves TEER values significantly after hypoxia (no inhibitor 266.167.7 OHM6cm
2 vs. Z-DEVD-
fmk: 317.3615.5 OHM6cm
2, n=6 coculture preparations, P,0.05).
doi:10.1371/journal.pone.0016760.g002
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that the close interactions between all cell types of the NVU need
to be considered in the pathophysiology of cerebrovascular
diseases. For example it has been demonstrated that glia is of
major importance for BBB injury in hypoxia [20,37]. Further-
more, it is known that hypoxia leads to cortical spreading
depression in neuronal circuits, which significantly disrupts BBB
integrity [38].
In this investigation we used models of the BBB, which imply a
preserved neuronal compartment with all cell types of the NVU
[15,18]. We postulate that the results of our in vitro approach are
therefore comparable to the in vivo situation. To our knowledge
our data demonstrate for the first time that the apoptosis protease
caspase-3 is rapidly activated and contributes to tight-junction
impairment in RANUD within minutes after onset of hypoxia.
Since the immediate depletion of oxygen and glucose metabolism
represents a very strong anoxic cell stress, we propose that this in
vitro OGD condition is mostly comparable to the ischemic core in
stroke in vivo. However, we also detected disruptions of ZO-1 after
MCAO in the cortical MCA territory of the guinea pig whole
brain preparation which resembles more closely the in vivo
situation. Although our experimental in vitro conditions do not
entirely reflect the in vivo situation during stroke (e.g. lack of blood
components). We propose that the phenomenon of RANUD is
Figure 3. Z-DEVD-fmk preserves TJ expression in brain endothelial cell membranes under OGD. Fluorescence intensity of ZO-1 and Cl-5
in cell membranes related to the fluorescence intensity of the cytoplasm: Cell membranes are represented by values in V1 and V3. The fluorescence
intensity of the cytoplasm is the average intensity of the distance V1-V3: V2. (A-E) Intensity histograms of ZO-1 in cells that were not pre-treated with
Z-DEVD-fmk before OGD (A and B) have lower peak values at cell membranes (B) related to the intensity of the cytoplasm of the corresponding cell.
(C and D) In contrast, high peak values in relation to the intensity of the cytoplasm were observed in cells that were pre-treated with Z-DEVD-fmk. (E)
Z-DEVD-fmk significantly preserved ZO-1 intensity at cell membranes under OGD (no inhibitor: 1.2460.1 vs. Z-DEVD-fmk: 1.8460.1, n=12 cells from 3
coculture preparations, P,0.001). (F–J) Quantification of Cl-5 at cell membranes demonstrates that Z-DEVD-fmk has a protective effect on Cl-5
alignment at cell membranes. (F) BEC with impaired Cl-5 expression at the cell membrane as shown in the corresponding linescan histogram (G). (H)
Preserved Cl-5 localization at the cell membrane in a BEC pre-treated with Z-DEVD-fmk before OGD with sustained peak values in the linescan
histogram (I). (J) Quantification of linescan histograms shows a significant protective effect of Z-DEVD-fmk for Cl-5 expression at cell membranes (no
inhibitor: 1.960.21 vs. Z-DEVD-fmk: 3.1960.41, n=12 cells from 3 coculture preparations, P,0.05).
doi:10.1371/journal.pone.0016760.g003
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PLoS ONE | www.plosone.org 6 February 2011 | Volume 6 | Issue 2 | e16760Figure 4. OGD induced microvascular TJ disruption is prevented by Z-DEVD-fmk. (A-D), Depletion of oxygen and glucose results in
disruptions of ZO-1 (arrowheads in A, C) and Cl-5 (arrowheads in B, D, I) in cortical microvessels in the NVU model. (E and F) Z-DEVD-fmk significantly
reduced gap formation in Cl-5 (15.3361.32% no inhibitor vs. 4.6960.84% +Z-DEVD-fmk, P,0.001, n=28–46 microvessels, 6–7 coculture preparations)
and ZO-1 (23.8762.15% no inhibitor vs. 12.5962.15% +Z-DEVD-fmk, P,0.001, n=26–42 microvessels, 6–7 coculture preparations) after 30 min of
OGD. (J-O) Here, Z-DEVD-fmk prevents disruptions of ZO-1 and Cl-5.
doi:10.1371/journal.pone.0016760.g004
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PLoS ONE | www.plosone.org 7 February 2011 | Volume 6 | Issue 2 | e16760very likely to be found in vivo after stroke because in good
agreement with our data Gerriets and colleagues [39] detected a
vasogenic edema formation with MR-imaging and Evan’s Blue
extravasation already after 20–45 min of permanent MCAO in an
in vivo rodent model without reperfusion. The results of Gerriets
and colleagues may be explained by RANUD in the ischemic core
region as demonstrated in the present report. However, the
protective effect of Z-DEVD-fmk and caspase-3 activation in our
study was observed in vitro.
The caspase-3 inhibitor Z-DEVD-fmk had a beneficial effect on
TEER and TJ alignment in BEC monolayers and cortical
microvessels. These findings are in good agreement with data
from Bojarski and colleagues [40], who previously documented a
protective effect on ZO-1 alignment in apoptotic Madine-Darby
canine kidney cells by inhibiting caspase-3 activity with Z-DEVD-
fmk. In our study Z-DEVD-fmk did not fully prevent ZO-1 or Cl-
5 disruptions and the loss of TEER after 30 min of OGD. The
protective effect of Z-DEVD-fmk in vitro on TEER was partial
Figure 5. ZO-1 disruption and MAP-2 damage in the guinea pig isolated whole brain after MCAO. (A-C) Cerebral microvessels have
continuous ZO-1 alignment in the control hemisphere, with only slight discontinuities in ZO-1 staining (arrowhead in C). (D) MAP-2 staining
demonstrates early hypoxic tissue damage after 30 min of MCAO without reperfusion in the occluded MCA-territory of the guinea pig whole brain.
The control hemisphere shows no hypoxic damage. (E-H) Numerous disruptions of ZO-1 in cortical microvessels were found after 30 min of MCAO
without reperfusion (arrowheads in E-H).
doi:10.1371/journal.pone.0016760.g005
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PLoS ONE | www.plosone.org 8 February 2011 | Volume 6 | Issue 2 | e16760Figure 6. OGD induced caspase-3 expression is only partially associated with DNA-fragmentation. (A, B) Positive TUNEL-labeling
demonstrates DNA-fragmentation after 30 min of OGD in the bEnd.3 cells (arrowheads in A and B). (C-F) Elevated levels of active caspase-3 (C and D:
red stained immunoreactive cleaved caspase-3) are only partially expressed in TUNEL positive cells (insets in E and F, note the fragmentation of the
nucleus in F). (G), Caspase-3 immunoreactivity is significantly higher (arrowheads H) after 30 min of OGD as compared to normoxic (arrowheads I)
conditions in the brain endothelial monolayer area of the neurovascular unit model (normoxia: 16.85%62.78% caspase-3 positive quadrants per cell
vs. OGD: 31.31%65.71% caspase-3 positive quadrants per cell, n=3 coculture preparations: 9 RFV per group, P,0.05).
doi:10.1371/journal.pone.0016760.g006
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PLoS ONE | www.plosone.org 9 February 2011 | Volume 6 | Issue 2 | e16760and is in concordance with the immunohistological findings of
ZO-1 and Cl-5 integrity, which were also not completely protected
by Z-DEVD-fmk after OGD. This result can be explained by the
fact, that other pathophysiological mechanisms contribute to
hypoxic BBB injury, like the formation of reactive oxygen species
[41], matrix metallo proteases [6], cytokines [42], excessive levels
of glutamate [15,41], phosphorylation of the myosin light chain
kinase [43], vascular endothelial growth factor [35], and cortical
spreading depression [38].
Our interpretion of a pivotal role of action of caspase-3 in
ischemic conditions is also supported by recent clinical datasets. It
has been shown that heightened serum levels of caspase-3 correlate
with poor outcome after stroke [12] and that minocycline, which is
known to inhibit caspase-3 expression [14] in vivo, has a beneficial
effect for patient outcome when administrated after stroke [13]. In
our study the amount of caspase-3 and TUNEL-positive cells
differed significantly. TUNEL-positive cells, which indicate DNA-
fragmentation [44], and the detection of active caspase-3 are
regarded as a good parameter for apoptosis [45]. Double stainings
showed more active caspase-3 than TUNEL-positive BEC after
30 min of OGD. Superimposed images of caspase-3 and TUNEL-
labeling revealed that active caspase-3 was only partly associated
with DNA-fragmentation.
We suggest that after 30 min OGD caspase-3 is rapidly
activated and alters ZO-1 and Cl-5 integrity, but does not lead
to DNA-fragmentation and apoptosis at the time point of 30 min
anoxia. An alternative explanation for the discrepancy between
TUNEL and caspase-3 staining could be an activation of caspase-
3 without cell death. It has been previously demonstrated that
hypoxia induced activation of caspase-3 does not necessarily
induce irreversible apoptotic cell death in neurons [46]. Moreover,
it has been recently also documented that caspase-3 plays a major
role in Alzheimer’s disease that is not instantaneously associated
with cell death [47]. These findings demonstrate that caspase-3
may also play a central role in neurodegenerative diseases
independently from apoptosis. However, active caspase-3 clearly
leads to apoptosis if the duration of hypoxia is expanded: Lee and
Lo [11] documented in a human brain endothelial cell model in
vitro that longer periods of hypoxia (4 hours) followed by
reoxygenation induce an activation of caspase-3 by matrix metallo
proteases causing apoptosis and DNA-fragmentation. Further
investigations are required to clarify the molecular pathways
involved in caspase-3 cleavage during RANUD. The observed TJ
alterations in our study could be caused by degradation of ZO-1
and Cl-5 via activated caspase-3. It has been shown that ZO-1 is a
cleavage substrate of caspase-3 [40] under apoptotic conditions. It
will be interesting to investigate whether this mechanism takes
place in our experimental setting and if Cl-5 is also a cleavage
substrate of caspase-3. Another important factor could be the
cytoskeleton protein actin. The cytoplasmic ZO-1 links actin
filaments and the transmembrane protein Cl-5 [1]. An impairment
of the actin filaments may therefore also lead to a dislocation of
ZO-1 and Cl-5. To evaluate these hypotheses further experimental
studies that deal with the molecular effector mechanism of
caspase-3 in RANUD within the neurovascular unit are required.
The rapid impairment of tight-junction proteins within minutes
after the onset of ischemia may not only be crucial for the
development of a vasogenic edema, but may also contribute to the
infiltration of inflammatory T-lymphocytes into the brain, as it has
been shown to be of decisive importance for delayed post-ischemic
brain inflammation [4]. Further in vivo investigations are required
to address this question.
In conclusion, our study demonstrates that tight-junction
disruption in the neurovascular unit may occur much earlier than
previously documented and does not depend on reoxygenation. In
addition we show that caspase-3 essentially contributes to ZO-1
and Cl-5 disruption in the early phase of ischemia while only
sparse DNA-fragmentation is detectable. Our results may be of
importance for the treatment and understanding of the pathogen-
esis of cerebral ischemia and delayed brain inflammation within
the neurovascular unit.
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